Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Wisdrug Innovative Drug Research (Beijing) Co. Ltd. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 distinct examiner and 1 distinct art unit, creating a focused prosecution path. Counsel can concentrate on the specific pharmaceutical or biotechnology claims, the cited record, and the technical support available in the application.
CONIGLIO, AUDREA JUNE BUCKLEY is the busiest examiner, with 1 pending matter. The examiner-specific record is central to planning the response, so a targeted analysis is appropriate. Any amendment should be tied closely to the disclosure and should address the stated issue without adding unsupported technical distinctions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CONIGLIO, AUDREA JUNE BUCKLEY | 1 | 53.1% | +20.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18827915 | PREDNISONE ENTERIC-COATED PREPARATION AND PREPARATION METHOD THEREOF | CONIGLIO, AUDREA JUNE BUCKLEY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18827915 | PREDNISONE ENTERIC-COATED PREPARATION AND PREPARATION METHOD THEREOF | CONIGLIO, AUDREA JUNE BUCKLEY | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18827915 | PREDNISONE ENTERIC-COATED PREPARATION AND PREPARATION METHOD THEREOF | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | §102§103§112 | Non-Final OA | — | Pending | Sep 09, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialWisdrug Innovative Drug Research (Beijing) Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Audrea June Buckley Coniglio has the most, with 1 of Wisdrug Innovative Drug Research (Beijing) Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
